ProJect Pharmaceutics and TUM-Spin-off ImevaX Announce Agreement

News   Dec 02, 2013

 
ProJect Pharmaceutics and TUM-Spin-off ImevaX Announce Agreement
 
 
 

RELATED ARTICLES

Tailoring Blood Cells in the Laboratory

News

Researchers are a step closer to growing blood cells customized to the special needs of transfusion patients with rare blood groups.

READ MORE

Older People’s Immune Cells Get a Fuzzier Set of Marching Orders than Youngsters

News

Discoveries may help explain why older people’s immune systems often don’t work so well, why different people’s immune systems age at different rates, and why the environment matters more than heredity in generating these age-related differences.

READ MORE

Feisty Fetal T Cells Can Rebel In Utero

News

Preterm labor, a common pregnancy complication, has long been a mystery to scientists. But a new study shows it may sometimes happen when the fetal immune system “wakes up” too early and begins to reject the mother, causing the uterus to start contracting.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE